PGIM India Healthcare Fund
Ticker: mf13724
Decent
68/100
☆ Add to Watchlist
More Options
S
Sundaram Nifty 100 Equal Weight Fund
The fund shows decent potential with a diversified approach, but caution is advised due to valuation concerns and execution risks.
View details
U
UTI NIFTY50 Equal Weight Index Fund
The UTI NIFTY50 Equal Weight Index Fund presents a decent investment opportunity with a balanced exposure to major companies, though some risks and valuation concerns exist.
View details
I
ICICI Pru Nifty50 Value 20 Index Fund
The ICICI Pru Nifty50 Value 20 Index Fund presents a decent investment opportunity with a balanced approach to value investing, though caution is advised due to market volatility and execution risks.
View details
Q
Quantum ESG Best In Class Strategy Fund
The Quantum ESG Best In Class Strategy Fund shows potential with a decent score, but investors should be cautious of valuation and execution risks.
View details
U
Union Dynamic Bond Fund
The Union Dynamic Bond Fund shows decent potential but faces challenges in profitability and market positioning.
View details
B
Bank of India Credit Risk Fund
The Bank of India Credit Risk Fund shows potential but faces challenges in growth consistency and valuation metrics. Investors should weigh the risks against the moderate growth prospects.
View details
B
Bandhan Conservative Hybrid Fund
The Bandhan Conservative Hybrid Fund shows decent potential but is not without its risks. Investors should weigh the moderate growth and profitability against the valuation concerns.
View details
K
Kotak Nifty SDL Jul 2026 Index Fund
The Kotak Nifty SDL Jul 2026 Index Fund presents a decent investment opportunity with stable returns, but investors should be cautious of market sentiment and potential execution risks.
View details
S
SBI Nifty200 Momentum 30 Index Fund
The SBI Nifty200 Momentum 30 Index Fund shows decent potential with a balanced approach to growth and profitability, but caution is advised due to some execution risks.
View details
B
Bandhan CRISIL IBX 90:10 SDL Plus Gilt - Nov 2026 Index Fund
The fund offers stability but lacks significant growth potential, making it suitable for conservative investors.
View details
N
Nippon India Quant Fund
The Nippon India Quant Fund shows decent potential with a solid growth trajectory and manageable risks, making it a reasonable investment option.
View details
B
Baroda BNP Paribas Income Plus Arbitrage Active FoF
The fund shows decent potential with stable growth and manageable risks, but lacks a strong competitive edge.
View details
I
ICICI Pru Retirement Fund-Pure Debt Plan
The fund presents a decent investment opportunity with stable returns, but growth potential is limited.
View details
N
Navi ELSS Tax Saver Nifty 50 Index Fund
The Navi ELSS Tax Saver Nifty 50 Index Fund shows decent potential for growth and stability, but investors should remain cautious of market risks and governance issues.
View details
K
Kotak FMP-308-1125D
The stock shows decent fundamentals but faces challenges in growth and profitability. Caution is advised.
View details
I
Invesco India - Invesco Global Equity Income FoF
The fund shows decent potential with stable growth and profitability metrics, but some risks in execution and liquidity should be monitored.
View details
Business Overview
The PGIM India Healthcare Fund is a dedicated mutual fund focusing on the dynamic healthcare sector. Ideal for investors seeking long-term growth through exposure to healthcare companies, this fund aims to capitalize on the increasing demand for healthcare services in India. With a professional management team and a robust investment strategy, it seeks to deliver attractive returns while managing risks effectively. This fund is crucial for those looking to diversify their portfolio with a focus on health and wellness.
- Focuses on the growing healthcare sector
- Ideal for long-term investors
- Professional management team
- Aims for attractive returns
- Diversifies investment portfolio
- Addresses increasing healthcare demand in India
Investment Thesis
PGIM India Healthcare Fund presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital healthcare services, and attractive valuation compared to peers. This fund is well-positioned to capitalize on the booming healthcare sector in India.
- Strong backing from PGIM, a reputable global investment management firm.
- Rapid growth in digital healthcare services, driven by increasing demand.
- Attractive valuation metrics compared to industry peers, enhancing upside potential.
- Focus on long-term healthcare trends, ensuring sustainable growth.
- Diversified portfolio aimed at mitigating risks while maximizing returns.
Opportunity vs Risk
Opportunities
- Growing healthcare sector in India
- Increased government healthcare spending
- Rising demand for health services
- Potential for high long-term returns
Risks ⚠️
- Market volatility affecting fund performance
- Regulatory changes in healthcare
- Economic downturn impacts investments
- High competition in healthcare sector
Peer Perspective
PGIM India Healthcare Fund trades at a slight premium compared to peers like SBI Healthcare Opportunities Fund and ICICI Prudential Healthcare Fund. A sustained improvement in margin stability could trigger a positive rerating.
📊 Stock Investment Checklist (100 Points)
PGIM India Healthcare Fund • Updated: 2025-09-29 15:10:19
-
10BusinessHighHealthcare sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are above industry average, but OCF is volatile.
-
8ValuationHighP/E and P/B ratios are higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
The fund shows potential for growth in the healthcare sector, but investors should be cautious of high valuations and execution risks.